Tongtawee Taweesak, Simawaranon Theeraya, Wattanawongdon Wareeporn, Dechsukhum Chavaboon, Leeanansaksiri Wilairat
Department of Surgery, Institute of Medicine, Suranaree University of Technology, Nakhon Ratchasima, Thailand.
School of Pathology, Institute of Medicine, Suranaree University of Technology, Nakhon Ratchasima, Thailand.
Turk J Gastroenterol. 2019 Jan;30(1):15-20. doi: 10.5152/tjg.2018.17461.
BACKGROUND/AIMS: Genetic polymorphisms in Toll-like receptors (TLRs) are important influence on gastric lesion development and Helicobacter pylori susceptibility.
TLR2 rs3804099 and rs3804100 and TLR4 rs10759932 were determined in a total of 400 patients. The association among genotypes and the risk of gastric lesion development and H. pylori susceptibility were evaluated by the odds ratios (ORs) and 95% confidence intervals (95% CIs) from logistic regression analyses.
TLR4 rs10759932, C/C homozygous genotype was associated with an increased risk of premalignant/malignant (OR=2.48, 95% CI=1.96-4.62, p=0.015). The recessive model of TLR4 rs10759932 showed a decreased risk of H. pylori susceptibility (adjusted OR=0.52, 95% CI=0.38-0.82, p=0.046). Meanwhile, the recessive model was associated with an increased risk of non-malignant (OR=3.46, 95% CI=2.25-5.67, p=0.001). In subjects with H. pylori infection, the recessive model was associated with an increased risk of non-malignant (OR=2.28, 95% CI=1.24-3.57, p=0.001) and premalignant/malignant (OR=1.83, 95% CI=1.16-2.84, p=0.027).
TLR4 rs10759932, but not TLR2 rs3804099 and rs3804100, was associated with risk of premalignant and/or malignant and H. pylori susceptibility. H. pylori infection seems to contribute to chronic gastritis, and premalignant/malignant supported the development of the premalignant/malignant lesions involved in H. pylori infection that is critical to gastric cancer in Thai patients.
背景/目的:Toll样受体(TLR)基因多态性对胃部病变发展及幽门螺杆菌易感性有重要影响。
对总共400例患者测定TLR2 rs3804099和rs3804100以及TLR4 rs10759932。通过逻辑回归分析的比值比(OR)和95%置信区间(95%CI)评估基因型与胃部病变发展风险及幽门螺杆菌易感性之间的关联。
TLR4 rs10759932的C/C纯合基因型与癌前/恶性病变风险增加相关(OR=2.48,95%CI=1.96 - 4.62,p=0.015)。TLR4 rs10759932的隐性模型显示幽门螺杆菌易感性风险降低(校正OR=0.52,95%CI=0.38 - 0.82,p=0.046)。同时,隐性模型与非恶性病变风险增加相关(OR=3.46,95%CI=2.25 - 5.67,p=0.001)。在幽门螺杆菌感染患者中,隐性模型与非恶性病变风险增加相关(OR=2.28,95%CI=1.24 - 3.57,p=0.001)以及癌前/恶性病变风险增加相关(OR=1.83,95%CI=1.16 - 2.84,p=0.027)。
TLR4 rs10759932而非TLR2 rs3804099和rs3804100与癌前和/或恶性病变风险及幽门螺杆菌易感性相关。幽门螺杆菌感染似乎导致慢性胃炎,并且癌前/恶性病变支持了幽门螺杆菌感染相关癌前/恶性病变的发展,这对泰国患者的胃癌至关重要。